Endpoints News Bulgaria
Company overview
Endpoints News is a media company that covers the most important events for leaders in the world of biopharma. Launched in 2015, Endpoints News has become the way drug development executives stay informed. Reported by a global team of journalists – led by co-founder John Carroll and executive editor Drew Armstrong – Endpoints covers news as it happens and delivers an inimitable twice-daily email newsletter to audiences interested in the discovery, research, marketing and regulation of biotech drugs.
In April 2023, the Financial Times acquired a controlling stake in Endpoints News. The Financial Times is one of the world’s leading business news organisations, recognised internationally for its credibility, integrity and accuracy. The FT has a record 1.2 million subscribing readers, of which more than one million are digital subscribers. It is part of Nikkei Inc. which provides a wide range of information, news and services to the global business community.
Activity
Product company
Sector
Media/ Biopharma/ Pharma
Central Office
Lawrence, Kansas, United States
Year of establishment:
2016
Employees worldwide
60
Established in Bulgaria
2019
Employees in Bulgaria:
4
Offices in Bulgaria
Sofia
IT Employees in Bulgaria
4
SASS 
JS 
PHP How we work
Annual leave
FT Bulgaria offers an annual leave of 25 days for all permanent employees.
Work from home
Completely remote positions.
Flexible Working Hours
Liberal, within reason.
Benefits
Health and insurance
Supplementary health insurance (including dental and psychological)
Employee Assistance Program (EAP) for employees and family members
Entertainment and discounts
Subsidised MultiSport card
Professional Development
Digital training as needed
Career counselling
Mentoring
Training seminars
Digital language training
Other
FT.com premium subscription
Free digital access to FT Live events
Extra insights
Key company services/products:
News, analysis, events, webinars, advertising in the pharmaceutical and biopharmaceutical industry.
